Search Results - "Tekmal, Rajeshwar"
-
1
Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury
Published in The Journal of neuroscience (09-12-2020)“…Expression of the 17β-estradiol (E2) synthesis enzyme aromatase is highly upregulated in astrocytes following brain injury. However, the precise role of…”
Get full text
Journal Article -
2
Brain-derived estrogen and neural function
Published in Neuroscience and biobehavioral reviews (01-01-2022)“…Brain-derived estrogen (BDE2) produced by the enzyme aromatase has several important functions in the brain. Work using aromatase inhibitors, aromatase…”
Get full text
Journal Article -
3
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo
Published in Biochemical pharmacology (01-02-2010)“…Curcumin, a yellow pigment present in the spice turmeric (Curcuma longa), has been linked with antioxidant, anti-inflammatory, antiproliferative, anticancer,…”
Get full text
Journal Article -
4
Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain
Published in The Journal of neuroscience (16-09-2020)“…17β-Estradiol (E2) is produced from androgens via the action of the enzyme aromatase. E2 is known to be made in neurons in the brain, but the functions of…”
Get full text
Journal Article -
5
Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression
Published in Cancer research (Chicago, Ill.) (15-06-2018)“…The estrogen receptor β (ERβ) functions as a tumor suppressor in glioblastoma (GBM) cells. However, the significance of endogenous ERβ and the roles of its…”
Get full text
Journal Article -
6
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma
Published in Neuro-oncology (Charlottesville, Va.) (06-07-2023)“…Abstract Background Efficient DNA repair in response to standard chemo and radiation therapies often contributes to glioblastoma (GBM) therapy resistance…”
Get full text
Journal Article -
7
Development and Evaluation of Talazoparib Nanoemulsion for Systemic Therapy of BRCA1 -mutant Cancer
Published in Anticancer research (01-08-2018)“…This is a debut study report on talazoparib (BMN-673)-loaded nanoemulsion (TZNE) for parenteral administration. TZNE (0.05% drug, 151.4±0.7 nm droplet size,…”
Get full text
Journal Article -
8
Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical Models
Published in Progress in Molecular Biology and Translational Science: Approaches to Understanding Breast Cancer (2017)“…Breast cancer is one of the most common cancers in the world. The majority of breast cancers express estrogen receptor (ER)α, and endocrine therapy is the…”
Get full text
Reference Journal Article -
9
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
Published in Molecular cancer therapeutics (01-08-2019)“…Leukemia inhibitory factor receptor (LIFR) and its ligand LIF play a critical role in cancer progression, metastasis, stem cell maintenance, and therapy…”
Get full text
Journal Article -
10
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
Published in Breast cancer research and treatment (01-01-2021)“…Purpose Cancer stem cells (CSCs) are highly tumorigenic, spared by chemotherapy, sustain tumor growth, and are implicated in tumor recurrence after…”
Get full text
Journal Article -
11
Neuron-Derived Estrogen-A Key Neuromodulator in Synaptic Function and Memory
Published in International journal of molecular sciences (08-12-2021)“…In addition to being a steroid hormone, 17β-estradiol (E ) is also a neurosteroid produced in neurons in various regions of the brain of many species,…”
Get full text
Journal Article -
12
SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
Published in Breast cancer research : BCR (08-04-2022)“…Methyltransferase SETDB1 is highly expressed in breast cancer (BC), however, the mechanisms by which SETDB1 promotes BC progression to endocrine therapy…”
Get full text
Journal Article -
13
Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential
Published in Biochemical pharmacology (01-06-2010)“…Thymoquinone (TQ), derived from the medicinal spice Nigella sativa (also called black cumin), has been shown to exhibit anti-inflammatory and anti-cancer…”
Get full text
Journal Article -
14
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer
Published in Cancer letters (01-01-2022)“…Endometrial cancer (EC) often exhibit aberrant activation of PI3K/Akt/mTOR signaling and targeted therapies using mTOR inhibitors showed limited success. The…”
Get full text
Journal Article -
15
Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist
Published in International journal of molecular sciences (28-06-2022)“…Ovarian cancer (OCa) is the deadliest gynecologic cancer. Emerging studies suggest ovarian cancer stem cells (OCSCs) contribute to chemotherapy resistance and…”
Get full text
Journal Article -
16
NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin-Aromatase Interactions
Published in Cancer research (Chicago, Ill.) (15-08-2014)“…Obesity is associated with a worse breast cancer prognosis and elevated levels of inflammation, including greater cyclooxygenase-2 (COX-2) expression and…”
Get full text
Journal Article -
17
Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells
Published in PloS one (02-04-2015)“…In postmenopausal women, local estrogen produced by adipose stromal cells in the breast is believed to support estrogen receptor alpha (ERα) positive breast…”
Get full text
Journal Article -
18
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma
Published in Molecular cancer therapeutics (01-11-2023)“…Glioblastoma (GBM) is the most prevalent and aggressive type of adult brain tumors with low 5-year overall survival rates. Epidemiologic data suggest that…”
Get full text
Journal Article -
19
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
Published in Cancer letters (28-10-2023)“…Ovarian cancer (OCa) is the most lethal gynecologic cancer. Emerging data indicates that estrogen receptor beta (ERβ) functions as a tumor suppressor in OCa…”
Get full text
Journal Article -
20
Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice
Published in Biology (Basel, Switzerland) (01-04-2023)“…17β-estradiol (E2) is produced in the brain as a neurosteroid, in addition to being an endocrine signal in the periphery. The current animal models for…”
Get full text
Journal Article